>>325
ã¹ããªãã客ã³ãããŠã€ã«ã¹èŠåãæ¹
ã¿ã€ã

éœæ§ã§éçè
ïŒäººå·¥åŒåžåšã€ããŠå
¥é¢äžïŒ1
ãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ

éœæ§ã§è»œçè
ïŒå³ãåºãïŒå
¥é¢äž
â
æ€æ»ãåããŠãªãã®ã§éœæ§é°æ§äžæã ãçç¶ãããè
ïŒå³ãåºãïŒå€æ° ã®ãã®ããšåå Žã«æ¥ãŠå³ããã
ãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ

éœæ§ã ãçç¶ãåºãŠãªã èªå®
éé€
æ€æ»ãåããŠãªããŠçç¶ããªã ã®ãã®ããšåå Žã«æ¥ãŠãã
ãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒãŒ

é°æ§
âââââââââââââââââââââââââââ
éææè
ïŒé°æ§ïŒããã¯ææããªããããã®é°æ§ã ãšããã£ãŠãã人ã¯å°ãªãã
æ€æ»æ¹æ³ã¯ïŒçš®é¡ããã
ã¬ã³ãã²ã³æ€æ»ãCOVID-19ç°¡ææ€æ»ãCOVID-19PCRæ€æ»ãCTæ€æ»ã
ãã¬ã³ãã²ã³æ€æ»ã
çœã圱ããã£ãŠãé°æ§éœæ§ãã確å®ããªãã
ãCOVID-19ç°¡ææ€æ»ã
PCRæ€æ»ã«æ¯ã¹ãŠæ床ãäœããã€ãŸãåœéœæ§ãåœé°æ§ãåºãããã
ãCOVID-19PCRæ€æ»ã
ç°¡ææ€æ»ããã¯æ床ãé«ããããã§ã70%ãã€ãŸãé°æ§ãšå€æããããªãã®3å²ã¯éœæ§ã§ããã
ãCTæ€æ»ã
粟å¯æ€æ»ãããã¯ééããªãããããããã®æ€æ»è²»çšã ãã§2äžåãããã